Skip to main content

Table 5 Treatment and outcome of patients with C. neoformans versus C. curvatus/C. laurentii meningitis

From: Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus/C. laurentii meningitis

Variable

Cryptococcal species

p

C. neoformans

na (%)b

C. curvatus/C. laurentii

na (%)b

Scheme of antifungal agents

0.09

 AFFc

22 (95.7)

4 (66.7)

 

 Fluconazole

0

1 (33.3)

 

Average hospital stay (day)

9.9 ± 6.01

12.4 ± 5.27

0.65

Therapeutic outcome

0.16

 Goodd

10 (43.5)

5 (83.3)

 

 Bade

13 (56.5)

1 (16.7)

 
  1. aWith available data
  2. bPercentage of columns calculated for each group
  3. cAmphotericin B + 5-flucytosine + fluconazole
  4. dRecovery and discharge from hospital
  5. eDeath, status quo, discharge against medical advice or transfer due to complications